Results 211 to 220 of about 12,639 (247)
Some of the next articles are maybe not open access.
neurogenetics, 2021
Proximal spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide, is an early-onset motor neuron disease characterized by loss of α-motor neurons and associated muscle atrophy. SMA is caused by deletion or other disabling mutations of survival motor neuron 1 (SMN1) but retention of one or more copies of the paralog SMN2. Within
Deborah L. Stabley +6 more
openaire +2 more sources
Proximal spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide, is an early-onset motor neuron disease characterized by loss of α-motor neurons and associated muscle atrophy. SMA is caused by deletion or other disabling mutations of survival motor neuron 1 (SMN1) but retention of one or more copies of the paralog SMN2. Within
Deborah L. Stabley +6 more
openaire +2 more sources
Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy
Neuromuscular Disorders, 2007Spinal muscular atrophy (SMA) is caused by homozygous deletion of the SMN1 gene in approximately 96% of cases. Four percent of SMA patients have a combination of the deletion or conversion on one allele and an intragenic mutation on the second one.
Eva, Zapletalová +9 more
openaire +2 more sources
Neuromuscular Disorders, 2008
In most patients with infantile spinal muscular atrophy (SMA) both exons 7 and 8 of the SMN1 gene are deleted, but the deletion may also be restricted to exon 7. We report on an SMA type I patient who was initially diagnosed to be homozygous for an exon 7 deletion only.
Thomas, Eggermann +4 more
openaire +2 more sources
In most patients with infantile spinal muscular atrophy (SMA) both exons 7 and 8 of the SMN1 gene are deleted, but the deletion may also be restricted to exon 7. We report on an SMA type I patient who was initially diagnosed to be homozygous for an exon 7 deletion only.
Thomas, Eggermann +4 more
openaire +2 more sources
Journal of Child Neurology, 2014
Proximal spinal muscular atrophy is an autosomal recessive disorder characterized by symmetrical muscle weakness due to degeneration of alpha motor neurons in the spinal cord. Homozygous deletions in the SMN1 have been reported in more than 90% of spinal muscular atrophy cases.
Hamid, Ganji +7 more
openaire +2 more sources
Proximal spinal muscular atrophy is an autosomal recessive disorder characterized by symmetrical muscle weakness due to degeneration of alpha motor neurons in the spinal cord. Homozygous deletions in the SMN1 have been reported in more than 90% of spinal muscular atrophy cases.
Hamid, Ganji +7 more
openaire +2 more sources
Spinal muscular atrophy carriers with two SMN1 copies
Brain and Development, 2017Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder. Over 95% of SMA patients have homozygous deletions of the SMA-causative gene, SMN1. Thus, SMA carriers are usually diagnosed based on SMN1 copy number, with one copy indicating SMA carrier status. However, two SMN1 copies do not always exclude carrier status. In this study,
Mawaddah, Ar Rochmah +13 more
openaire +2 more sources
Russian Journal of Genetics, 2015
Type I–IV proximal spinal muscular atrophy (SMA) is one of the most common autosomal-recessive diseases, which are characterized in the majority of cases by a severely disabling course. Proximal SMA results from mutations in the telomeric copy of SMN1 gene.
V. V. Zabnenkova +5 more
openaire +3 more sources
Type I–IV proximal spinal muscular atrophy (SMA) is one of the most common autosomal-recessive diseases, which are characterized in the majority of cases by a severely disabling course. Proximal SMA results from mutations in the telomeric copy of SMN1 gene.
V. V. Zabnenkova +5 more
openaire +3 more sources
Human Mutation, 2004
Spinal muscular atrophy (SMA) is a common autosomal recessive disease. SMA is linked to the 5q13 locus in 95% of patients, and in at least 98% of them, the SMN1 homozygous deletion is found. Compound heterozygous patients, who have an SMN1 deletion associated with a subtle mutation, appear undeleted with the common molecular diagnostic test that ...
Olivier, Clermont +6 more
openaire +2 more sources
Spinal muscular atrophy (SMA) is a common autosomal recessive disease. SMA is linked to the 5q13 locus in 95% of patients, and in at least 98% of them, the SMN1 homozygous deletion is found. Compound heterozygous patients, who have an SMN1 deletion associated with a subtle mutation, appear undeleted with the common molecular diagnostic test that ...
Olivier, Clermont +6 more
openaire +2 more sources
Human Genetics, 2002
Autosomal recessive spinal muscular atrophy (SMA) is a disease resulting from mutations in the telomeric survival motor neuron gene ( SMN1). In our sample of 150 Spanish SMA families, 87% of patients had homozygous deletions of SMN1. To identify patients who retained a single SMN1 copy, SMN dosage analysis was performed by a fluorescent quantitative ...
Yolanda, Martín +4 more
openaire +2 more sources
Autosomal recessive spinal muscular atrophy (SMA) is a disease resulting from mutations in the telomeric survival motor neuron gene ( SMN1). In our sample of 150 Spanish SMA families, 87% of patients had homozygous deletions of SMN1. To identify patients who retained a single SMN1 copy, SMN dosage analysis was performed by a fluorescent quantitative ...
Yolanda, Martín +4 more
openaire +2 more sources
Genetic Testing and Molecular Biomarkers, 2014
Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder caused by mutations of the survival of motor neuron 1 (SMN1) gene. Approximately 90-95% of SMA patients have a homozygous deletion of SMN1, and 5-10% of patients are believed to have subtle mutations.
Jin-Li, Bai +10 more
openaire +2 more sources
Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder caused by mutations of the survival of motor neuron 1 (SMN1) gene. Approximately 90-95% of SMA patients have a homozygous deletion of SMN1, and 5-10% of patients are believed to have subtle mutations.
Jin-Li, Bai +10 more
openaire +2 more sources
2022
Monogenik bir nöromusküler hastalık olan spinal musküler atrofi (SMA) motor nöron hücrelerinin kaybı olarak ilerleyen otozomal resesif bir hastalıktır. SMN1 geninin delesyonu ile nöron hücre kaybı yaşanmaktadır. Etkin bir tedavisi günümüzde olmamakla beraber SMA hastalığı SMN2 ekspresyonunu artırarak ya da SMN1 benzeri proteinlerin üretilmesiyle ...
Yazır, Yusufhan, Duruksu, Gökhan
openaire +1 more source
Monogenik bir nöromusküler hastalık olan spinal musküler atrofi (SMA) motor nöron hücrelerinin kaybı olarak ilerleyen otozomal resesif bir hastalıktır. SMN1 geninin delesyonu ile nöron hücre kaybı yaşanmaktadır. Etkin bir tedavisi günümüzde olmamakla beraber SMA hastalığı SMN2 ekspresyonunu artırarak ya da SMN1 benzeri proteinlerin üretilmesiyle ...
Yazır, Yusufhan, Duruksu, Gökhan
openaire +1 more source

